Global News

Six pharmas employing Epic Sciences’ circulating tumor cell technology

Wednesday, August 15, 2012 10:38 AM

Epic Sciences, a privately held cancer diagnostics company of La Jolla, Calif., has established collaborations with six pharmaceutical partners employing Epic’s proprietary Circulating Tumor Cell (“CTC”) technology.

More... »

AZ, Pfizer enter agreement for OTC Nexium

Wednesday, August 15, 2012 09:41 AM

AstraZeneca, a global biopharmaceutical company, has entered into an agreement with Pfizer, a global research-based pharmaceutical company, for the over-the-counter (OTC) rights for Nexium (esomeprazole magnesium), a prescription drug currently approved to treat the symptoms of gastroesophageal reflux disease (GERD).

More... »

Quintiles acquires Expression Analysis to advance personalized medicine

Monday, August 13, 2012 12:02 PM

Quintiles, a fully integrated biopharmaceutical services company, has acquired Expression Analysis (EA), a Durham, N.C.-based provider of genomics testing and analysis to biopharma, academic, government and non-profit customers. Terms of the transaction were not disclosed.

More... »

Pluristem, Cato Research collaborate on intermittent claudication

Monday, August 13, 2012 11:32 AM

Pluristem Therapeutics, a developer of placenta-based cell therapies based in Israel, has selected Cato Research as its CRO for the German portion of the company's phase II trial in intermittent claudication (IC) under the auspices of the Paul-Ehrlich Institute (PEI).

More... »

Sun Pharmaceutical to acquire Taro

Monday, August 13, 2012 09:57 AM

Sun Pharmaceutical Industries, an Indian specialty pharmaceutical company, and Taro Pharmaceutical Industries, a multinational pharmaceutical company, have entered into a merger agreement together with certain affiliates of Sun Pharma.

More... »

PAREXEL International announces CFO transition

Friday, August 10, 2012 02:11 PM

PAREXEL International, a global bio/pharmaceutical services organization, announced that James F. Winschel, Jr., senior vice president and CFO, will transition to the position of executive vice president at PAREXEL upon appointment of a new CFO. 

More... »

Aquavit, Green Cross sign strategic collaboration MOU on IBX-001

Friday, August 10, 2012 12:07 PM

Aquavit Pharmaceuticals, a multi-specialty healthcare company of New York, and Green Cross, a South Korean biotechnology company, signed a Memorandum of Understanding (MOU) towards establishing their strategic collaboration surrounding the development and commercialization of Aquavit's IBX-001 in Asia.

More... »

ALS Association announces $4M in research grants for Lou Gehrig's disease

Friday, August 10, 2012 11:43 AM

The ALS Association has awarded $4 million in research grants to researchers in 31 laboratories across the U.S., U.K., Belgium, Germany and Canada to find treatments and a cure for Lou Gehrig's disease (ALS)

More... »

Platinum-Montaur finances $20M to Echo Therapeutics

Friday, August 10, 2012 11:29 AM

Platinum-Montaur Life Sciences has agreed to provide Echo Therapeutics, a transdermal medical device company, a credit facility of up to $20 million.

More... »

Accu-Break, Alembic enter into product development and license agreement

Friday, August 10, 2012 11:02 AM

India-based Accu-Break Pharmaceuticals (ABP) has entered into a development and license agreement with Alembic Pharmaceuticals of Plantation, Fla., to develop new brand products that will use ABP’s innovative Accu-Break tablet technologies.

More... »